Latest blog articles
-
The Ius Commune Workshop on Contract Law took place on 25 November with its main theme being Empirical Research in Contract Law. During the workshop, five presenters reported on either their fully-fledged projects or shared ideas on early-stage studies.
-
Some of the favourite expressions of online platform providers around the world are that they ‘only offer a platform’ and are ‘in no way responsible for statements made or goods offered by third parties on their platform’. However, recent US case law held Amazon liable for physical harm caused by...
-
The yearly Ius Commune conference, this year held online on 26 November 2020, traditionally includes a contract law workshop. This year the theme of the workshop was “Contract law in times of corona and other sanitary crises”. Five researchers presented recent work dealing with subthemes.
-
The annual Ius Commune conference and its contract law workshop on “Contract law in times of corona and other sanitary crises”.
-
How do we guarantee access to COVID-19 vaccines and therapies, and secure health-related human rights for all? We’ve heard a string of promises in the race for new vaccines and therapies.
-
It’s been almost a month since the COVID-19 pandemic has drastically changed the way we live and work. Now that we are more used to, in a manner of speaking, the extraordinary measures to curtail the rampant spread of the virus, it’s time to seriously consider, and openly discuss, this crisis’...
-
Asylum-seekers at the Greek island of Lesbos are in a vulnerable position. They claim basic human rights and hold the Europeans accountable. What can a human rights scholar do? His role is limited. When there is no political will, compassion and solidarity are gone.
-
The 70th anniversary of the Universal Declaration of Human Rights and the 25th anniversary of the Maastricht Centre for Human Rights are a landmark in the development of human rights and a source of inspiration for academic research on new global human rights issues.
-
Globally the majority of health-related R&D is invested in medicines with substantial guaranteed returns, yet what is missing is extensive R&D targeted at diseases overwhelmingly prevalent in developing countries. This threatens long-term availability of medicines and treatment options for these...